Peptide Libraray

Sequence 28 from Patent US 20060122119

General Information

DCTPep ID DCTPep01281

Peptide Name Sequence 28 from Patent US 20060122119

Sequence TPRLPSSADV

Sequence Length 10

UniProt ID P11344 Q8MIU0 P54834 Q9BDE0 P55033 P14679

PubChem CID Not available

Origin Homo sapiens

Type Native peptide

Classification

ACP

Activity Information

Hemolytic Activity Not available

Normal (non-cancerous) Cytotoxicity Not available

Target Not available

Affinity Not available

Mechanism Not available

Structure Information

PDB ID Not available

Predicted Structure Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity Not available

Linear/Cyclic Not available

Disulfide/Other Bond Not available

N-terminal Modification Not available

C-terminal Modification Not available

Other Modification None

Chiral L

Physicochemical Information

Formula C44H75N13O16

Absent amino acids CEFGHIKMNQWY

Theoretical pI 5.50

Acidic residues 1

Basic residues 1

Polar residues 3

Molecular weight (Average) 1042.16

Molecular weight (Monoisotopic) 1041.55

Common amino acids PS

Net charge 0

Instability index (II) 50.75

Aliphatic index 78.00

Grand average of hydropathicity (GRAVY) -0.370

Half Life
7.2 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).

Extinction coefficients
Should not be visible by UV spectrophotometry.

Amino acid distribution

Literature Information

Literature 1

Pubmed ID Not available

Title Not available

Doi Not available

Year Not available

Patent

Patent ID US 2006/0122119 A1

Patent Title Peptides for use in antitumor immunotherapy.

Other Iinformation Granted Patent Family: 10s / 10ex; Family Jurisdictions: CA, AU, FR, WO, US, EP, JP; Legal Status: Discontinued; Application No: 50633405; Filed:May 25, 2005; Published: Jun 8, 2006; Earliest Priority: Mar 4, 2002

Other Published ID CA2477762A1 EP1481009A2 WO2003074565A2 WO2003074565A3